126 related articles for article (PubMed ID: 8908183)
1. Research on the mechanisms of action of aneugenic chemicals and regulatory approaches for their control in the European Communities.
Parry JM
Environ Mol Mutagen; 1996; 28(3):248-53. PubMed ID: 8908183
[TBL] [Abstract][Full Text] [Related]
2. Aneuploidy: a report of an ECETOC task force.
Aardema MJ; Albertini S; Arni P; Henderson LM; Kirsch-Volders M; Mackay JM; Sarrif AM; Stringer DA; Taalman RD
Mutat Res; 1998 Feb; 410(1):3-79. PubMed ID: 9587424
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of mechanisms of action of aneugenic chemicals.
Parry EM; Parry JM; Corso C; Doherty A; Haddad F; Hermine TF; Johnson G; Kayani M; Quick E; Warr T; Williamson J
Mutagenesis; 2002 Nov; 17(6):509-21. PubMed ID: 12435848
[TBL] [Abstract][Full Text] [Related]
4. The detection and evaluation of aneugenic chemicals.
Parry JM; Parry EM; Bourner R; Doherty A; Ellard S; O'Donovan J; Hoebee B; de Stoppelaar JM; Mohn GR; Onfelt A; Renglin A; Schultz N; Söderpalm-Berndes C; Jensen KG; Kirsch-Volders M; Elhajouji A; Van Hummelen P; Degrassi F; Antoccia A; Cimini D; Izzo M; Tanzarella C; Adler ID; Kliesch U; Hess P
Mutat Res; 1996 Jun; 353(1-2):11-46. PubMed ID: 8692188
[TBL] [Abstract][Full Text] [Related]
5. The analysis of the activity of aneugenic chemicals, from cultured cells to rodent zygotes: an overview of the Protection of the European Population from Aneugenic Chemicals (PEPFAC project).
Parry JM
Mutat Res; 2008 Mar; 651(1-2):1-2. PubMed ID: 18082443
[No Abstract] [Full Text] [Related]
6. The detection and assessment of the aneugenic potential of environmental chemicals: the European Community Aneuploidy Project.
Parry JM; Sors A
Mutat Res; 1993 May; 287(1):3-15. PubMed ID: 7683383
[TBL] [Abstract][Full Text] [Related]
7. Regulatory recognition of indirect genotoxicity mechanisms in the European Union.
Pratt IS; Barron T
Toxicol Lett; 2003 Apr; 140-141():53-62. PubMed ID: 12676451
[TBL] [Abstract][Full Text] [Related]
8. Risks of aneuploidy induction from chemical exposure: Twenty years of collaborative research in Europe from basic science to regulatory implications.
Kirsch-Volders M; Pacchierotti F; Parry EM; Russo A; Eichenlaub-Ritter U; Adler ID
Mutat Res Rev Mutat Res; 2019; 779():126-147. PubMed ID: 31097149
[TBL] [Abstract][Full Text] [Related]
9. Targets and mechanisms of chemically induced aneuploidy. Part 1 of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases.
Lynch AM; Eastmond D; Elhajouji A; Froetschl R; Kirsch-Volders M; Marchetti F; Masumura K; Pacchierotti F; Schuler M; Tweats D
Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403025. PubMed ID: 31699346
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.
Parry JM; Jenkins GJ; Haddad F; Bourner R; Parry EM
Mutat Res; 2000 Jan; 464(1):53-63. PubMed ID: 10633177
[TBL] [Abstract][Full Text] [Related]
11. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 41. Can a 'relatively simple' screening procedure for the detection of chemicals with aneugenic potential be recommended at the moment?
Miller BM; Madle S; Albertini S
Mutat Res; 1994 Jan; 304(2):303-7. PubMed ID: 7506374
[No Abstract] [Full Text] [Related]
12. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two in vitro mammalian cell cytogenetic assays for the detection of mitotic aneuploidy using 10 known or suspected aneugens.
Warr TJ; Parry EM; Parry JM
Mutat Res; 1993 May; 287(1):29-46. PubMed ID: 7683382
[TBL] [Abstract][Full Text] [Related]
14. The use of the in vitro micronucleus assay to detect and assess the aneugenic activity of chemicals.
Parry JM; Parry EM
Mutat Res; 2006 Aug; 607(1):5-8. PubMed ID: 16723272
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of tests for aneuploidy.
Parry JM; Parry EM
Mutat Res; 1987 Dec; 181(2):267-87. PubMed ID: 3317028
[TBL] [Abstract][Full Text] [Related]
16. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
17. Genetic toxicology testing requirements: official and unofficial views from Europe.
Kirkland DJ
Environ Mol Mutagen; 1993; 21(1):8-14; discussion 46-57. PubMed ID: 8419157
[TBL] [Abstract][Full Text] [Related]
18. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds.
Kirkland DJ; Müller L
Mutat Res; 2000 Jan; 464(1):137-47. PubMed ID: 10633186
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
